NCT02352129View on ClinicalTrials.gov

Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy

NACompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

January 31, 2017

Study Completion Date

June 30, 2017

Conditions
Cardiomyopathy, Dilated
Interventions
OTHER

CMR using T1 mapping technique

the level of myocardial fibrosis for patient suffering of cardiomyopathy dilated will be quantified using CMR T1 mapping technique

Trial Locations (1)

13354

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02352129 - Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy | Biotech Hunter | Biotech Hunter